Microphysiological Systems standard NCATS Tissue Chip Program IQ Consortium MPS affiliate NASA Tissue chips in space EMA + FDA Regulatory qualification Multi-organ Body-on-chip Microphysiological Systems standard NCATS Tissue Chip Program IQ Consortium MPS affiliate NASA Tissue chips in space EMA + FDA Regulatory qualification Multi-organ Body-on-chip
Biological MPS Platforms

The BioMPS Standard

Biological microphysiological systems represent the gold standard in human-relevant testing. BioMPS platforms combine living cells, tissue engineering, and microfluidics to predict drug safety and efficacy with unprecedented accuracy.

LIVER HEART KIDNEY GUT LUNG BRAIN MULTI-ORGAN BioMPS
$1.5B
MPS Market 2030
12+
Organ Types
90%
Clinical Translation
35%
CAGR Growth

BioMPS Capabilities

Comprehensive human biology on a platform

🧬

Multi-Organ Systems

Connect multiple organ chips fluidically to model systemic drug distribution, metabolism, and off-target effects across the body.

🔬

Physiological Flow

Perfusion at physiological shear rates and pressures. Blood surrogate or real blood for immune-competent systems.

📈

PBPK Integration

Combine MPS data with computational PBPK models for in silico human predictions. Quantitative systems pharmacology.

🎯

Disease States

Model NASH, fibrosis, inflammation, infection, and cancer on-chip. Patient-derived cells for personalized disease avatars.

High-Content Readouts

Imaging, omics, electrophysiology, and biosensors. Multi-parametric data for mechanistic understanding.

💡

Regulatory Path

IND-enabling studies accepted by FDA. ISTAND program validation. Path to replacing animal studies in drug development.

Own the BioMPS Brand

BioMPS.com - Premium domain for microphysiological systems. Ideal for platforms, consortia, or commercial applications.

Contact for Pricing
Redirecting to PatientAnalog.com in 20s